These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

362 related items for PubMed ID: 19132985

  • 1. Prognostic value of COX-2 immunohistochemical expression evaluated by quantitative image analysis in colorectal cancer.
    Zafirellis K, Agrogiannis G, Zachaki A.
    APMIS; 2008 Oct; 116(10):912-22. PubMed ID: 19132985
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of VEGF expression evaluated by quantitative immunohistochemical analysis in colorectal cancer.
    Zafirellis K, Agrogiannis G, Zachaki A, Gravani K, Karameris A, Kombouras C.
    J Surg Res; 2008 Jun 01; 147(1):99-107. PubMed ID: 17655863
    [Abstract] [Full Text] [Related]

  • 3. [Expression of COX-2 protein in colorectal carcinoma and the clinical implication].
    Yao HB, Wu AG, Chen YJ, Tang BH.
    Di Yi Jun Yi Da Xue Xue Bao; 2005 Dec 01; 25(12):1524-8. PubMed ID: 16361154
    [Abstract] [Full Text] [Related]

  • 4. Inducible nitric oxide synthase expression and its prognostic significance in colorectal cancer.
    Zafirellis K, Zachaki A, Agrogiannis G, Gravani K.
    APMIS; 2010 Feb 01; 118(2):115-24. PubMed ID: 20132175
    [Abstract] [Full Text] [Related]

  • 5. Differential expression of alpha-methylacyl-coenzyme A racemase in colorectal carcinoma bears clinical and pathologic significance.
    Lin A, Weiser MR, Klimstra DS, Paty PB, Tang LH, Al-Ahmadie H, Hoo Park S, Guillem JG, Temple L, Wong WD, Gerald WL, Shia J.
    Hum Pathol; 2007 Jun 01; 38(6):850-6. PubMed ID: 17442371
    [Abstract] [Full Text] [Related]

  • 6. Relationship between COX-2 expression and clinicopathological features of colorectal cancers.
    Zhan J, Liu JP, Zhu ZH, Yao HR, Chen CY.
    Chin Med J (Engl); 2004 Aug 01; 117(8):1151-4. PubMed ID: 15361286
    [Abstract] [Full Text] [Related]

  • 7. Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy.
    Giralt J, Navalpotro B, Hermosilla E, de Torres I, Espin E, Reyes V, Cerezo L, de las Heras M, Ramon y Cajal S, Armengol M, Benavente S.
    Oncology; 2006 Aug 01; 71(5-6):312-9. PubMed ID: 17687192
    [Abstract] [Full Text] [Related]

  • 8. Cyclooxygenase-2 expression in human colorectal cancer is unrelated to overall patient survival.
    Fux R, Schwab M, Thon KP, Gleiter CH, Fritz P.
    Clin Cancer Res; 2005 Jul 01; 11(13):4754-60. PubMed ID: 16000571
    [Abstract] [Full Text] [Related]

  • 9. Identification of immunohistochemical prognostic markers for survival after resection of pulmonary metastases from colorectal carcinoma.
    Pfannschmidt J, Bade S, Hoheisel J, Muley T, Dienemann H, Herpel E.
    Thorac Cardiovasc Surg; 2009 Oct 01; 57(7):403-8. PubMed ID: 19795327
    [Abstract] [Full Text] [Related]

  • 10. P53 and EGFR expression in colorectal cancer: a reappraisal of 'old' tissue markers in patients with long follow-up.
    Theodoropoulos GE, Karafoka E, Papailiou JG, Stamopoulos P, Zambirinis CP, Bramis K, Panoussopoulos SG, Leandros E, Bramis J.
    Anticancer Res; 2009 Feb 01; 29(2):785-91. PubMed ID: 19331236
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prognostic value of CD44 expression in colorectal carcinomas.
    Sökmen S, Lebe B, Sarioglu S, Füzün M, Terzi C, Küpelioglu A, Ellidokuz H.
    Anticancer Res; 2001 Feb 01; 21(6A):4121-6. PubMed ID: 11911305
    [Abstract] [Full Text] [Related]

  • 13. COX-2 expression in malignant melanoma: a novel prognostic marker?
    Becker MR, Siegelin MD, Rompel R, Enk AH, Gaiser T.
    Melanoma Res; 2009 Feb 01; 19(1):8-16. PubMed ID: 19430402
    [Abstract] [Full Text] [Related]

  • 14. [Correlation between Stat3 signal transduction pathway and expression of cyclooxygenase-2 in colorectal cancer cells].
    Zhang H, Wang S, Zhang YC, Ye YJ, Cui ZR, Fang WG.
    Zhonghua Yi Xue Za Zhi; 2005 Nov 02; 85(41):2899-904. PubMed ID: 16324362
    [Abstract] [Full Text] [Related]

  • 15. Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.
    Yoo PS, Sullivan CA, Kiang S, Gao W, Uchio EM, Chung GG, Cha CH.
    Ann Surg Oncol; 2009 Jan 02; 16(1):200-7. PubMed ID: 19009247
    [Abstract] [Full Text] [Related]

  • 16. Prognostic relevance of cyclooxygenase-2 (COX-2) expression in Chinese patients with prostate cancer.
    Bin W, He W, Feng Z, Xiangdong L, Yong C, Lele K, Hongbin Z, Honglin G.
    Acta Histochem; 2011 Feb 02; 113(2):131-6. PubMed ID: 19836060
    [Abstract] [Full Text] [Related]

  • 17. Cyclooxygenase-2 overexpression correlates with tumour recurrence, especially haematogenous metastasis, of colorectal cancer.
    Tomozawa S, Tsuno NH, Sunami E, Hatano K, Kitayama J, Osada T, Saito S, Tsuruo T, Shibata Y, Nagawa H.
    Br J Cancer; 2000 Aug 02; 83(3):324-8. PubMed ID: 10917546
    [Abstract] [Full Text] [Related]

  • 18. Overexpression of cyclooxygenase-2 correlates with advanced stages of colorectal cancer.
    Zhang H, Sun XF.
    Am J Gastroenterol; 2002 Apr 02; 97(4):1037-41. PubMed ID: 12003384
    [Abstract] [Full Text] [Related]

  • 19. Cyclooxygenase-2 expression is related to prognosis in patients with esophageal squamous cell carcinoma.
    Takatori H, Natsugoe S, Okumura H, Matsumoto M, Uchikado Y, Setoyama T, Sasaki K, Tamotsu K, Owaki T, Ishigami S, Aikou T.
    Eur J Surg Oncol; 2008 Apr 02; 34(4):397-402. PubMed ID: 17553653
    [Abstract] [Full Text] [Related]

  • 20. MMP-9 (gelatinase B) expression is associated with disease-free survival and disease-specific survival in colorectal cancer patients.
    Bendardaf R, Buhmeida A, Hilska M, Laato M, Syrjänen S, Syrjänen K, Collan Y, Pyrhönen S.
    Cancer Invest; 2010 Jan 02; 28(1):38-43. PubMed ID: 20001295
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.